Evidence map›Paper›PMID 18258476›Full record

ReviewCytokine & growth factor reviews2008

Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Patrick Blanco, A Karolina Palucka, Virginia Pascual, Jacques Banchereau

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine & growth factor reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 247 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
247citing papers in PubMed, 3 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

247 citing papers in PubMed, 3 syntheses or guidelines pooled it, 553 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Deciphering defensive mechanisms inFrontiers in immunology · 2026
    Review
  18. Review
  19. Article
  20. Article

187 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Patrick BlancoCHU Bordeaux, 33076 Bordeaux, France. patrick.blanco@chu-bordeaux.fr
A Karolina Palucka
Virginia Pascual
Jacques Banchereau
Baylor University · USCentre Hospitalier Universitaire de Bordeaux · FR

Funding

Targeting Dendritic Cells for Enhanced Musocal ImmunityU19AI057234 · NIAID · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 2003 to 2013
$49.2M
Induction of melanoma immunity by dendritic cell subsetsP01CA084512 · NCI · ROCKEFELLER UNIVERSITY · PI BANCHEREAU, JACQUES F · 2000 to 2010
$12.1M
Neutrophils in Lupus PathogenesisP50AR054083 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2006 to 2010
$6.2M
Use of Microarrays to Understand Systemic ArthritisR01AR050770 · NIAMS · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2003 to 2012
$3.1M
SUBPOPULATIONS OF HUMAN DENDRITIC CELLSR01CA078846 · NCI · BAYLOR RESEARCH INSTITUTE · PI BANCHEREAU, JACQUES F · 1999 to 2008
$2.5M
NCI NIH HHS P01 CA084512NCI NIH HHS R01 CA078846NIAID NIH HHS U19 AI057234NIAMS NIH HHS P50 AR054083NIAMS NIH HHS R01 AR050770NIAMS NIH HHS R0-1 AR050770-01
6 · The paper itself

Abstract

Dendritic cells (DCs) produce cytokines and are susceptible to cytokine-mediated activation. Thus, interaction of resting immature DCs with TLR ligands, for example nucleic acids, or with microbes leads to a cascade of pro-inflammatory cytokines and skewing of T cell responses. Conversely, several cytokines are able to trigger DC activation (maturation) via autocrine, for example TNF and plasmacytoid DCs, and paracrine, for example type I IFN and myeloid DCs, pathways. By controlling DC activation, cytokines regulate immune homeostasis and the balance between tolerance and immunity. The increased production and/or bioavailability of cytokines and associated alterations in DC homeostasis have been implicated in various human inflammatory and autoimmune diseases. Targeting these cytokines with biological agents as already is the case with TNF and IL-1 represents a success of immunology and the coming years will expand the range of cytokines as therapeutic targets in autoinflammatory and autoimmune pathology.

Indexed as

Autoimmune DiseasesAutoimmunityCytokinesDendritic CellsHMGB1 ProteinHumansImmune ToleranceInflammationInterferon-alphaInterferon Type IInterleukin-1Interleukin-12Interleukin-6Toll-Like ReceptorsTumor Necrosis Factor-alphaCytokinesHMGB1 ProteinInterferon-alphaInterferon Type IInterleukin-1Interleukin-12Interleukin-6Toll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID18258476
PMCPMC2413068
OpenAlexW2078009629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.